BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 35476279)

  • 1. Reductions in HbA1c with Flash Glucose Monitoring Are Sustained for up to 24 Months: A Meta-Analysis of 75 Real-World Observational Studies.
    Evans M; Welsh Z; Seibold A
    Diabetes Ther; 2022 Jun; 13(6):1175-1185. PubMed ID: 35476279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Real-world study of flash glucose monitoring among adults with type 2 diabetes within the Swedish National Diabetes Register.
    Eeg-Olofsson K; Svensson AM; Franzén S; Ahmed Ismail H; Törnblom M; Levrat-Guillen F
    Diab Vasc Dis Res; 2023; 20(1):14791641211067418. PubMed ID: 36715353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Impact of Flash Glucose Monitoring on Glycaemic Control as Measured by HbA1c: A Meta-analysis of Clinical Trials and Real-World Observational Studies.
    Evans M; Welsh Z; Ells S; Seibold A
    Diabetes Ther; 2020 Jan; 11(1):83-95. PubMed ID: 31673972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improving HbA1c Control in Type 1 or Type 2 Diabetes Using Flash Glucose Monitoring: A Retrospective Observational Analysis in Two German Centres.
    Rose L; Klausmann G; Seibold A
    Diabetes Ther; 2021 Jan; 12(1):363-372. PubMed ID: 33314006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FreeStyle Libre Flash Glucose Monitoring system for people with type 1 diabetes in the UK: a budget impact analysis.
    Blissett R; Blissett D; Levrat-Guillen F; Deshmukh H; Wilmot EG; Ryder REJ; Walton C; Sathyapalan T
    BMJ Open Diabetes Res Care; 2022 Mar; 10(2):. PubMed ID: 35346970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Freestyle libre flash glucose monitoring improves patient quality of life measures in children with Type 1 diabetes mellitus (T1DM) with appropriate provision of education and support by healthcare professionals.
    Pintus D; Ng SM
    Diabetes Metab Syndr; 2019; 13(5):2923-2926. PubMed ID: 31425957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Meta-analysis of average change in laboratory-measured HbA1c among people with type 1 diabetes mellitus using the 14 day Flash Glucose Monitoring System.
    Gordon I; Rutherford C; Makarounas-Kirchmann K; Kirchmann M
    Diabetes Res Clin Pract; 2020 Jun; 164():108158. PubMed ID: 32333970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determinants of HbA1c reduction with FreeStyle Libre flash glucose monitoring (FLARE-NL 5).
    Lameijer A; Fokkert MJ; Edens MA; Slingerland RJ; Bilo HJG; van Dijk PR
    J Clin Transl Endocrinol; 2020 Dec; 22():100237. PubMed ID: 33102135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-Effectiveness of the FreeStyle Libre
    Jendle J; Eeg-Olofsson K; Svensson AM; Franzen S; Lamotte M; Levrat-Guillen F
    Diabetes Ther; 2021 Dec; 12(12):3137-3152. PubMed ID: 34694584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing Diabetes Distress and Sleep Quality in Young Adults with Type 1 Diabetes Using FreeStyle Libre: A Prospective Cohort Study.
    Al Hayek AA; Al Dawish MA
    Diabetes Ther; 2020 Jul; 11(7):1551-1562. PubMed ID: 32495021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The FreeStyle Libre flash glucose monitoring system: how it has improved glycaemic control for people with type 1 diabetes in Eastern Cheshire, UK.
    Yadegarfar G; Anderson SG; Khawaja Z; Cortes G; Leivesley K; Metters A; Horne L; Steele T; Heald AH
    Cardiovasc Endocrinol Metab; 2020 Dec; 9(4):171-176. PubMed ID: 33225233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost Analysis of FreeStyle Libre
    Oyagüez I; Gómez-Peralta F; Artola S; Carrasco FJ; Carretero-Gómez J; García-Soidan J; Gómez-Huelgas R; Merino-Torres JF; Pérez A
    Diabetes Ther; 2021 Sep; 12(9):2329-2342. PubMed ID: 33948909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sensor-Based Technology: Bringing Value to People with Diabetes and the Healthcare System in an Evolving World.
    Glennie JL; Berard L; Levrat-Guillen F
    Clinicoecon Outcomes Res; 2022; 14():75-90. PubMed ID: 35177913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Flash glucose monitoring in type 2 diabetes managed with basal insulin in the USA: a retrospective real-world chart review study and meta-analysis.
    Carlson AL; Daniel TD; DeSantis A; Jabbour S; Karslioglu French E; Kruger D; Miller E; Ozer K; Elliott T
    BMJ Open Diabetes Res Care; 2022 Jan; 10(1):. PubMed ID: 35058312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of FreeStyle Libre Flash Glucose Monitoring System Implementation in Real Life Clinical Setting: A Prospective Observational Study.
    Canecki Varzic S; Steiner K; Gradinjan Centner M; Grgurevic M; Cigrovski Berkovic M; Klobucar Majanovic S; Radman M; Milicevic T; Rahelic D; Bilic Curcic I
    Diagnostics (Basel); 2021 Feb; 11(2):. PubMed ID: 33668675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of flash glucose-sensing technology (FreeStyle Libre) in youth with type 1 diabetes: AWeSoMe study group real-life observational experience.
    Landau Z; Abiri S; Gruber N; Levy-Shraga Y; Brener A; Lebenthal Y; Barash G; Pinhas-Hamiel O; Rachmiel M
    Acta Diabetol; 2018 Dec; 55(12):1303-1310. PubMed ID: 30171412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systematic review and meta-analysis of the effectiveness of continuous glucose monitoring (CGM) on glucose control in diabetes.
    Poolsup N; Suksomboon N; Kyaw AM
    Diabetol Metab Syndr; 2013; 5():39. PubMed ID: 23876067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of the FreeStyle Libre flash glucose monitoring system on diabetes- self-management practices and glycemic control among patients with type 2 diabetes in Saudi Arabia: A prospective study.
    Al Hayek A; Robert AA; Al Dawish M
    Diabetes Metab Syndr; 2021; 15(2):557-563. PubMed ID: 33689937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness and Safety of the Intermittently Scanned Continuous Glucose Monitoring System FreeStyle Libre 2 in Patients with Type 2 Diabetes Treated with Basal Insulin or Oral Antidiabetic Drugs: An Observational, Retrospective Real-World Study.
    Conti M; Massari G; Meneghini E; Pasquino B; Agosti B; Chinotti F; Pintaudi B; Girelli A; Bertuzzi F
    J Clin Med; 2024 Jan; 13(3):. PubMed ID: 38337336
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.